Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Leandro Ivaldi"'
Autor:
Leandro Ivaldi, Alexander Bertuccioli, Francesco Di Pierro, Rosanna Giuberti, Mariella Saponara
Publikováno v:
Minerva gastroenterologica e dietologica. 66(1)
Background Berberine, an alkaloid obtained by extraction from Berberis spp., is a botanical that is widely used in the nutraceutical sector to control cholesterol and blood glucose levels. It is also a molecule that is effective in limiting diarrhea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::132506db8bf07ff287fddcc9f16cc562
https://pubmed.ncbi.nlm.nih.gov/32283882
https://pubmed.ncbi.nlm.nih.gov/32283882
Publikováno v:
Minerva gastroenterologica e dietologica. 66(1)
Background In Western countries functional dyspepsia (FD) has a prevalence of 10-20% among adults and although many drugs are currently available for use within clinical practice, FD remains an important challenge for physicians. Recently, food suppl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b6d6fd8d36b04ca2ff6f1362732bed2
https://pubmed.ncbi.nlm.nih.gov/35040303
https://pubmed.ncbi.nlm.nih.gov/35040303
Publikováno v:
Minerva gastroenterologica e dietologica. 66(2)
Background Results from the meta-analysis of randomized controlled studies demonstrate that the adjuvant use of probiotics enhances the rate of Helicobacter pylori (Hp) eradication, reducing concomitantly the occurrence of side effects, mainly diarrh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1245cbb3d4530427ed24596ac0b9bc1
https://pubmed.ncbi.nlm.nih.gov/32272820
https://pubmed.ncbi.nlm.nih.gov/32272820
Publikováno v:
Minerva Gastroenterologica e Dietologica. 65
BACKGROUND In medical practice, the use of rifaximin and a probiotic is quite common in patients with a diagnosis of symptomatic uncomplicated diverticular disease (SUDD), with the latter being administered at the end of the rifaximin cycle. The oppo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bd50f7103e71645ce1179afed247d02
https://doi.org/10.23736/s1121-421x.19.02622-9
https://doi.org/10.23736/s1121-421x.19.02622-9
Publikováno v:
Clinical and Experimental Gastroenterology
Francesco Di Pierro,1 Alexander Bertuccioli,2 Eleonora Marini,3 Leandro Ivaldi4 1Velleja Research, Milan, Italy; 2Italian Association Fitness and Medicine, Fano, PU, Italy; 3Pharmextracta, Pontenure, Piacenza, Italy; 4Digestive Endoscopic Department,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::170d5782c63cb48e65e2f985b9010c66
https://www.dovepress.com/a-pilot-trial-on-subjects-with-lactose-andor-oligosaccharides-intolera-peer-reviewed-article-CEG
https://www.dovepress.com/a-pilot-trial-on-subjects-with-lactose-andor-oligosaccharides-intolera-peer-reviewed-article-CEG
Publikováno v:
Clinical and Experimental Gastroenterology
Francesco Di Pierro,1 Mario Gatti,2 Giuliana Rapacioli,3 Leandro Ivaldi4 1Velleja Research, Milan, 2Gastroenterology Department, Giussano Hospital, Monza-Brianza, 3AIOR, Piacenza, 4Digestive Endoscopic Department, Ceva Hospital, Ceva, Cuneo, Italy Ba
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02f6260f534d704183b2110b31258ea8
https://www.dovepress.com/outcomes-in-patients-with-nonerosive-reflux-disease-treated-with-a-pro-peer-reviewed-article-CEG
https://www.dovepress.com/outcomes-in-patients-with-nonerosive-reflux-disease-treated-with-a-pro-peer-reviewed-article-CEG